孕期糖尿病及其对小脑发育的影响:对实验研究的叙述性审查
Mohammad Javad Saeedi Borujeni1, Pilar Codoner Franch2, Eulalia Alonso Iglesias3
1Department of Medical Basic Sciences, Islamic Azad University, Isfahan (Khorasgan) Branch, Isfahan, Iran.
Iranian journal of child neurology
|April 15, 2024
概括
孕期糖尿病 (GDM) 对胎儿小脑发育产生负面影响,导致结构和分子变化. 胰岛素治疗可以减轻糖尿病母亲后代的这些不良影响.
科学领域:
- 神经科学是一个神经科学.
- 发展生物学 发展生物学
- 内分泌学 在内分泌学.
背景情况:
- 孕期糖尿病 (GDM) 是一种常见的妊娠并发症,对胎儿发育的影响尚不清楚.
- 新出现的证据表明,GDM对正在发育的小脑产生不利影响,这对认知和行为功能至关重要.
研究的目的:
- 审查母亲糖尿病对胎儿小脑发育的影响.
- 探索胰岛素治疗在缓解GDM诱导的大脑小脑变化的潜力.
主要方法:
- 对调查母亲糖尿病和后代小脑发育的研究进行文献综述.
- 对胎儿小脑中报告的结构,细胞和分子变化的分析.
主要成果:
- 母亲GDM可以破坏小脑皮质形态发生,减少小脑体积,改变皮质层厚度.
- 在发育中的小脑中,GDM会影响神经元细胞和基因表达 (synaptophysin,胰岛素,IGF-1受体).
- 在GDM怀孕中服用胰岛素似乎可以减少这些细胞和分子变化.
结论:
- GDM具有神经毒性风险,可能导致后代的功能和结构异常.
- 胰岛素治疗在抵消GDM诱导的小脑发育缺陷方面显示出有前途.
- 孕妇GDM的普遍查对于早期干预至关重要.
相关概念视频
Pathophysiology of Diabetes
924
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
924
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Diabetes: Symptoms, Diagnosis, and Complications
528
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
528
Inborn Errors of Metabolism
157
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
157


